After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Most recently, Yahoo Finance reported about the stock as it publicized that Seres Therapeutics to Host Fourth Quarter 2023 Financial Results and Operational Progress Conference Call and Webcast on March 5, 2024.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Seres Therapeutics Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. At the end of the last regular session, the stock closed at $1.15 and fluctuated between $1.2300 as its day high and $1.1300 as its day low. The current market capitalization of Seres Therapeutics Inc is $148.65M. A total of 4.3 million shares were traded on the day, compared to an average of 4.56M shares.
Insider Activity
Insider trades are also considered as indicators of how a stock will perform in the future, in addition to stock predictions. During the recent three months, MCRB has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 10 BUYs and 9 SELLs from insiders. Insiders purchased 175,556 shares during that period but sold 41,807.
In the most recent transaction, Shaff Eric D. sold 11,549 shares of MCRB for 1.08 per share on Feb 16. After the transaction, the CEO and President now owns 135,321 company shares. In a previous transaction on Feb 16, Ege David S. sold 5,010 shares at 1.08 per share. MCRB shares that the insider owns now total 73,856.
Among the insiders who sold shares, von Moltke Lisa disposed of 4,400 shares on Feb 16 at a per-share price of $1.08. This resulted in the insider holding 16,988 shares of MCRB after the transaction. In another insider transaction, Henn Matthew R. sold 4,170 shares at $1.08 per share on Feb 16. Company shares held by the insider now total 63,436.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. According to analysts who have offered 12-month price targets for MCRB in the last 3 months, the mean price target is $9.02 with high estimates of $15.00 and low estimates of $1.10. In terms of 52-week highs and lows, MCRB has a high of $6.87 and a low of $0.91.
As of this writing, MCRB has an earnings estimate of -$0.5 per share for the current quarter. EPS was calculated based on a consensus of 7 estimates, with a high estimate of -$0.33 per share and a lower estimate of -$1. The company reported an EPS of $0.36 in the last quarter, which was -32.10% lower than expectations of $0.53.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. MCRB’s latest balance sheet shows that the firm has $290.71M in Cash & Short Term Investments as of fiscal 2021. There were $49.21M in debt and $82.26M in liabilities at the time. Its Book Value Per Share was -$0.12, while its Total Shareholder’s Equity was $131.51M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for MCRB is Buy with a score of 4.67.
